Detalhe da pesquisa
1.
A novel approach to estimate the local population denominator to calculate disease incidence for hospital-based health events in England.
Epidemiol Infect
; 150: e150, 2022 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35811424
2.
A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.
BMC Pulm Med
; 16(1): 77, 2016 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27169895
3.
Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK.
Vaccine
; 42(7): 1599-1607, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38336560
4.
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom.
Expert Rev Vaccines
; 22(1): 785-800, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37694398
5.
Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease.
Expert Rev Pharmacoecon Outcomes Res
; 22(8): 1285-1295, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36225103
6.
Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and retrospective methodology.
BMJ Open
; 12(6): e057464, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705333
7.
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England.
Expert Rev Vaccines
; 21(9): 1331-1341, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929956
8.
Hospitalization costs of adult community-acquired pneumonia in England.
J Med Econ
; 25(1): 912-918, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726515
9.
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study.
Lancet Reg Health Eur
; 21: 100473, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35965672
10.
Identifying UK travellers at increased risk of developing pneumococcal infection: a novel algorithm.
J Travel Med
; 28(6)2021 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978186
11.
A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK.
Expert Rev Vaccines
; 20(10): 1311-1325, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34550850
12.
Co-diagnoses of acute myeloid leukaemia and COVID-19: presentation and management implications.
Respirol Case Rep
; 8(7): e00650, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32864140
13.
Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England.
BMJ Open Respir Res
; 7(1)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33051218
14.
Safety and Efficacy of Anidulafungin for Fungal Infection in Patients With Liver Dysfunction or Multiorgan Failure.
Open Forum Infect Dis
; 4(1): ofw241, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28480239
15.
Community-acquired pneumonia in the United Kingdom: a call to action.
Pneumonia (Nathan)
; 9: 15, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29043150
16.
Response to Dawson et al: Letter to the Editor on ''A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK''.
Expert Rev Vaccines
; 21(6): 871-872, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35226814
17.
The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development.
Vaccine
; 38(51): 8068-8070, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190949